ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Arno Therapeutics Inc (CE)

Arno Therapeutics Inc (CE) (ARNI)

0.0001
0.00
(0.00%)
Closed November 26 4:00PM

Empower your portfolio: Real-time discussions and actionable trading ideas.

Key stats and details

Current Price
0.0001
Bid
0.00
Ask
0.00
Volume
-
0.00 Day's Range 0.00
0.000058 52 Week Range 0.0003
Previous Close
0.0001
Open
-
Last Trade
Last Trade Time
Average Volume (3m)
9,989
Financial Volume
-
VWAP
-

ARNI Latest News

Arno Therapeutics, Inc. Appoints Alexander Zukiwski, M.D. as Interim Chief Executive Officer and Mr. Lawrence Kenyon as Chief...

FLEMINGTON, N.J., July 18, 2014 (GLOBE NEWSWIRE) -- Arno Therapeutics, Inc. (OTCQB:ARNI), a clinical stage biopharmaceutical company focused on the development of oncology therapeutics, today...

Arno Therapeutics to Present at the Jefferies 2014 Global Healthcare Conference

FLEMINGTON, N.J., May 29, 2014 (GLOBE NEWSWIRE) -- Arno Therapeutics, Inc. (OTCQB:ARNI), a clinical stage biopharmaceutical company focused on the development of oncology therapeutics, today...

Arno Therapeutics Reports First Quarter 2014 Financial and Business Update

FLEMINGTON, N.J., May 15, 2014 (GLOBE NEWSWIRE) -- Arno Therapeutics, Inc. (OTCQB:ARNI), a clinical stage biopharmaceutical company focused on the development of oncology therapeutics, today...

Arno Therapeutics to Outline Two Phase I Studies Evaluating Onapristone in Men's and Women's Cancers at 2014 ASCO Annual Meet...

Studies to determine recommended Phase II dose and safety profile of lead compound Will analyze relationship of biomarker to any anti-tumor activity observed FLEMINGTON, N.J., May 14, 2014...

Arno Therapeutics Announces Clinical Abstracts Accepted at 2014 ASCO Annual Meeting

FLEMINGTON, N.J., May 5, 2014 (GLOBE NEWSWIRE) -- Arno Therapeutics, Inc. (OTCQB:ARNI), a clinical stage biopharmaceutical company focused on the development of oncology therapeutics, today...

Arno Therapeutics Enrolls First Patient in a Phase I/II Trial Evaluating Onapristone in Men with Advanced Castration-Resistan...

FLEMINGTON, N.J., April 7, 2014 (GLOBE NEWSWIRE) -- Arno Therapeutics, Inc. (OTCQB:ARNI), a clinical stage biopharmaceutical company focused on the development of oncology therapeutics, today...

Arno Therapeutics Reports 2013 Financial Results and Provides Update on Strategic and Operational Milestones

FLEMINGTON, N.J., April 1, 2014 (GLOBE NEWSWIRE) -- Arno Therapeutics, Inc. (OTCQB:ARNI), a clinical stage biopharmaceutical company focused on the development of oncology therapeutics, today...

Arno Therapeutics to Present Three New Studies Supporting the Clinical Development of Onapristone at AACR Annual Meeting 2014...

FLEMINGTON, N.J., March 26, 2014 (GLOBE NEWSWIRE) -- Arno Therapeutics, Inc. (OTCQB:ARNI), a clinical stage biopharmaceutical company focused on the development of oncology therapeutics, today...

Arno Therapeutics Board of Directors Appoints Randy Thurman as Vice Chairman

FLEMINGTON, N.J., March 24, 2014 (GLOBE NEWSWIRE) -- Arno Therapeutics, Inc. (OTCQB:ARNI), a clinical stage biopharmaceutical company focused on the development of oncology therapeutics, today...

Arno Therapeutics to Present at 26th Annual ROTH Conference

FLEMINGTON, N.J., March 5, 2014 (GLOBE NEWSWIRE) -- Arno Therapeutics, Inc. (OTCQB:ARNI), a clinical stage biopharmaceutical company focused on the development of oncology therapeutics, today...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10000000CS
4000.00010.00010.00018000.0001CS
12-0.0002-66.66666666670.00030.00030.000199890.0001CS
26-0.0002-66.66666666670.00030.00030.000149940.0001CS
524.2E-572.41379310345.8E-50.00035.8E-537570.00012027CS
156-0.002-95.23809523810.00210.00211.0E-663667.33E-5CS
260-0.0017-94.44444444440.00180.0421.0E-6633660.00487412CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
TMPOQTempo Automation Holdings Inc (CE)
$ 0.005
(499,900.00%)
100
FUNFFFansUnite Entertainment Inc (CE)
$ 0.0006
(59,900.00%)
268.14k
SWWISimon Worldwide Inc (GM)
$ 0.0005
(49,900.00%)
300
AMMJAmerican Cannabis Company Inc (CE)
$ 0.0004
(39,900.00%)
7.45k
MGTIMGT Capital Investments Inc (CE)
$ 0.0002
(19,900.00%)
261.83k
CRMBQCrumbs Bake Shop Inc (CE)
$ 0.000001
(-99.99%)
200
EMWPFEros Media World PLC (CE)
$ 0.000001
(-99.95%)
100
CNONFLynx Global Digital Finance Corporation (CE)
$ 0.000001
(-99.90%)
1.85k
DEERDeer Consumer Products Inc (CE)
$ 0.000001
(-99.90%)
3.6k
CAFSCafe Serendipity Holdings Inc (CE)
$ 0.000001
(-99.50%)
5k
HMBLHUMBL Inc (PK)
$ 0.0003
(20.00%)
151.08M
ABQQAB International Group Corporation (PK)
$ 0.001
(25.00%)
142M
THBDThird Bench Inc (PK)
$ 0.0001
(0.00%)
128.56M
RDARRaadr Inc (PK)
$ 0.001
(0.00%)
109.04M
ASTAAstra Veda Corporation (PK)
$ 0.0002
(0.00%)
93.24M

Discussion

View Full Feed
Guzzi62 Guzzi62 2 minutes ago
OS grew 43,000,000 in Q3 alone. That's 3.5%. This management team depreciated the value of your investment by 3.5% in one quarter alone, with just equity distribution. Forget the price plummeting. If you own 100,000 shares, they just reached into your pocket and grabbed 3500 shares for themselves fo
NWBO
bri123 bri123 3 minutes ago
Total Shi*show. no matter whom runs it. maybe we get a year-end-run good enough to get my money back (that's my Christmas wish).
THBD
BDEZ BDEZ 3 minutes ago
Yeah, before Tucker was let go i'm sure...
BDEZ BDEZ 4 minutes ago
Never saw that one! Thanks CT!
joyceschoice joyceschoice 4 minutes ago
Doublethink, not doublespeak. It's been long time since I last read it. Anyway it's 2024, not 1984 and here we are.
dinogreeves dinogreeves 5 minutes ago
All debt paid off. Lets see their game plan now.

https://www.otcmarkets.com/filing/html?id=18006601&guid=FQY-kHnuV5SJh3h
SMCI
littlejohn littlejohn 5 minutes ago
VRT is selling at about 3 times higher

valuation rate on forward p/e projected...

https://finance.yahoo.com/quote/SMCI/key-statistics/

https://finance.yahoo.com/quote/VRT/key-statistics/

SMCI has a Charles Liang as CEO...

VRT
SMCI VRT
Crapola2theleft Crapola2theleft 5 minutes ago
It's about TIME! The ps will jump. Best of all, lives will start being saved!!!
NWBO
Talon38 Talon38 5 minutes ago
Ignatius.....Although the EMA may not require a commercial pathway/plan, one could see they would want to see one in place when it was a major Alzheimer's drug they approved.
AVXL
Golden Cross Golden Cross 7 minutes ago
$BQST BioQuest, Inc. and BotMakers Expand AI Marketing Services with SpeedLeads XL and MarketScope XL
https://www.accesswire.com/947312/bioquest-inc-and-botmakers-expand-ai-marketing-services-with-speedleads-xl-and-marketscope-xl
BQST
ChannelTrader ChannelTrader 8 minutes ago
Don't know but it's good.
JPetroInc JPetroInc 8 minutes ago
celebrity involvement …???

I was thinking more along the lines of a few guppy celeb’s or something

but no…MONI is swimming with internationally acclaimed celebrity “whales” with $20-Mil. and $10-Bil. net worths - are they kidding ….?

simple unreal AB…!
MONI
boston127 boston127 8 minutes ago
Do not give up. The managemt is good.

- They got out of China (Hong Kong) after realizing that most listed Chinese companies are full of hot air and "unclean" financials.
- They are in highly respected Singapore, which is more demanding about financials.
- They are
LGHL
SSKILLZ1 SSKILLZ1 8 minutes ago
Pitching is starting to sign. Dodgers just signed Snell to a monster 5/182 million deal, they sure do spend money. A couple of days back Angels sign Kikuchi for 3/63. Hopefully soto signs soon, so mets whether they get him or not (Hopefully they get him) starting filling in the massive holes in the
gfp927z gfp927z 8 minutes ago
Bar, I haven't owned it, but did have a number of Berkshire's stock holdings in my own portfolio. With Apple, Buffet had always shunned tech stocks, but he said that Apple was an exception due to the amazingly strong brand loyalty that it had with its users. But it's still tech, and subject to
JohnnyRotton JohnnyRotton 8 minutes ago
If the gold is minable, it will go up, if it isn't it won't.

Buy at .0001
NBRI
Rocky3 Rocky3 9 minutes ago
the partner will share development costs or take it on entirely, enta will retain a stake in the asset, and suddenly you are at 18 cash plus royalty, plus value of the RSV asset

For the record, the shareholder equity is down from ~$10/sh to ~$6/sh over the last 12 months. I know that
ENTA
oneragman oneragman 9 minutes ago
Sleven, the buyback and every other "action" taken by management has been a con. I mean what the hell was that investor conference? I didn't need someone to tell me how great the drug is. I need someone to tell me how they are going to make money. At this point, what is the plan? They just had an in
AMRN
dmsrz8 dmsrz8 9 minutes ago
So not a lot of comments here of late. Looks promising 
PODC
Genz2 Genz2 10 minutes ago
Methinks, coming up on this thanksgiving, my mother went into a long term care facility and she got to see her favorite person, Donald Trump win the election!! I am thankful for that as I think she wouldn’t have made it this far if he lost!! I am absolutely CONVINCED that she is his #1
FFFacts FFFacts 10 minutes ago
Quit posting links to your stupid x account. If you want to post from x learn to embed it so people dont have to click on your stupid link.
FNMA
BDEZ BDEZ 10 minutes ago
Great clip, thanks CT. Wonder when that was?

Shows Tucker on Foxweiser...
BamaBreeze BamaBreeze 11 minutes ago
You also!! And other positive shareholders.  Maybe another pump will happen (and be true and honest)!
BLLB
hardlesson hardlesson 11 minutes ago
Lol, well you won't have to worry about that, because you changed your sell order at .001, down to .0009 today, as you were the first one to point them out.

Except you weren't expecting such an appetite for more at .0009, and .0008.

Whether we hold this area or don't,
SHMN